Evidence map›Paper›PMID 31606081›Full record

ArticleMethods in enzymology2019

Analysis of the topology of ubiquitin chains.

Lucia Geis-Asteggiante, Amanda E Lee, Catherine Fenselau

Abstract read
In one paragraph

Article in Methods in enzymology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. The Ubiquitin Tale: Current Strategies and Future Challenges.ACS pharmacology & translational science · 2024
    Review
  2. Quantitative Analysis of Diubiquitin Isomers Using Ion Mobility Mass Spectrometry.Journal of the American Society for Mass Spectrometry · 2023
    Article
  3. Review
  4. The ubiquitin proteoform problem.Current opinion in chemical biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lucia Geis-AsteggianteDepartment of Chemistry and Biochemistry, University of Maryland, College Park, MD, United States.
Amanda E LeeDepartment of Chemistry and Biochemistry, University of Maryland, College Park, MD, United States.
Catherine FenselauDepartment of Chemistry and Biochemistry, University of Maryland, College Park, MD, United States. Electronic address: fenselau@umd.edu.

Funding

Solution structure and dynamics of polyubiquitin chainsR01GM065334 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI DAVID FUSHMAN · 2002 to 2026
$6.2M
Ubiquitinated Proteins in Exosomes of Immune Suppressive Myeloid CellsR01GM021248 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI FENSELAU, CATHERINE C, FUSHMAN, DAVID · 1985 to 2017
$4.6M
Orbitrap Fusion Tribrid Mass SpectrometerS10OD019938 · OD · UNIV OF MARYLAND, COLLEGE PARK · PI FENSELAU, CATHERINE C · 2015 to 2015
$600k
APPLICATIONS OF MASS SPECTROMETRY IN PHARMACOLOGYR37GM021248 · NIGMS · UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS · PI FENSELAU, CATHERINE C. · 1992 to 2001
$438k
NIGMS NIH HHS R01 GM021248NIGMS NIH HHS R01 GM065334NIGMS NIH HHS R37 GM021248NIH HHS S10 OD019938
6 · The paper itself

Abstract

The small protein ubiquitin and its multiple polymers are encountered free in cells and as post-translational modifications on all proteins. Different polyubiquitin three dimensional structures are shown to correlate uniquely with different cellular functions as part of the diverse ubiquitin signaling. At the same time, this multiplicity of structures provides serious challenges to the analytical biochemist. Globally applicable strategies are presented here for the analyses of polyubiquitins and of ubiquitinated proteins, which take advantage of the speed, specificity and sensitivity of top-down tandem mass spectrometry. Particular attention is given to the supervised interpretation of fragmentation as revealed in the MS/MS spectra of these branched proteins. The strategy is compatible with any MS activation technology, is applicable to all polyubiquitin linkage and chain types, can be extended to ubiquitin-like proteins, and will be compatible with and enhanced by continuing advances in LC-MS/MS instrumentation and interpretation software.

Indexed as

UbiquitinationAmino Acid SequenceAnimalsChromatography, High Pressure LiquidHumansPolyubiquitinProtein ConformationProtein MultimerizationTandem Mass SpectrometryUbiquitinUbiquitinated ProteinsPolyubiquitinUbiquitinUbiquitinated ProteinsBranched proteinsPolyubiquitin topologyRub1Synthetic polyubiquitinSynthetic ubiquitin conjugatesTop-down mass spectrometryUbiquitinUbiquitin-like proteinsUbiquitin linkage sites

Identifiers

PMID31606081
PMCPMC6989142

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.